Ublituximab + TGR-1202 Demonstrates Activity and a Favorable Safety Profile in Relapsed/Refractory B-Cell NHL and High-Risk CLL: Phase I Results
| Autor: | Lunning, Matthew A., Vose, Julie, Fowler, Nathan, Nastoupil, Loretta, Burger, Jan A., Wierda, William, Schreeder, Marshall T., Siddiqi, Tanya, Flowers, Christopher, Cohen, Jonathon B., Blumel, Susan *, Miguel, Myra *, Cutter, Kathy *, Pauli, Emily K. *, Handy, Ryan *, Sportelli, Peter, Miskin, Hari P. *, Weiss, Michael S. *, O'Brien, Susan |
|---|---|
| Zdroj: | In Blood 3 December 2015 126(23):1538-1538 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|